UNSPSC 51342904: Vidarabine

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3XQD2MEW34, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but generally known as vidarabine, which bears US NIH Compound Identifier 191. European Medicines Agency schedules Vidarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00047MIG.

UNSPSC 51342904 Vidarabine is a Commodity code that nominally identifies a specific antiviral pharmaceutical; however, recent state and local procurement activity under this code shows substantial mismatch with the code's narrow scope. The solicitations tagged to this code are actually purchasing broader categories of pharmaceuticals, medical supplies, and pharmacy benefit management services rather than vidarabine specifically. Seminole County, Florida is procuring naloxone and drug deactivation systems through an IFB; the City of Tampa is soliciting medical and first aid supplies for fire rescue operations through an IFB; Texas HHS is gathering market intelligence on direct-to-manufacturer prescription fulfillment through an RFI; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is establishing master contracts for generic multi-source pharmaceuticals and OTC products through an RFP. These opportunities reflect state and local demand for pharmaceutical sourcing, emergency medical supplies, and pharmacy logistics support rather than for vidarabine as a discrete product line.

Activity under this code spans multiple states — Florida, Texas, and Minnesota/Oregon are represented in recent solicitations — and encompasses diverse issuing bodies including county health departments, city fire departments, state health agencies, and multistate cooperative purchasing vehicles. The geographic spread and issuing-body mix suggest that while the code may nominally designate a single pharmaceutical substance, state and local procurement offices are using it as a catch-all for pharmaceutical and medical supply categories more broadly. The Seminole County naloxone procurement (IFB 60459723LAS, due July 26, 2023) and the City of Tampa medical supplies procurement (IFB 26P00145, estimated at $700,000.00, due March 13, 2026, sheltered for Small Local Business Enterprises with a 5 percent bid discount) are the most concrete and recent examples of active procurements under this code. Given the code's nominal scope and the actual work being bought, vendors pursuing opportunities under UNSPSC 51342904 should expect to compete for pharmaceutical, medical supply, and pharmacy benefit services work rather than vidarabine-specific contracting.